ICD-10 Code B44.9 | Aspergillosis, unspecified Symptoms, Diagnosis, Billing

Aspergillosis, unspecified is a fungal infection caused by the Aspergillus species, which can lead to respiratory issues and systemic complications. Accurate coding with ICD-10 Code B44.9 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B44.9 for Aspergillosis, unspecified?

ICD-10 Code B44.9 represents Aspergillosis, unspecified, a condition characterized by infection due to the Aspergillus fungus. This code is used when the specific type of aspergillosis is not identified. It is crucial for clinical documentation and billing when a patient presents with symptoms of aspergillosis without a specified subtype.

ICD-10 Code B44.9 – Clinical Definition and Explanation of Aspergillosis, unspecified

Aspergillosis, unspecified is primarily caused by inhalation of Aspergillus spores, which can lead to respiratory infections, particularly in immunocompromised individuals. The condition may progress to severe pulmonary disease or disseminated infection, necessitating prompt medical attention.

Key Clinical Features:

• Common symptoms include cough, fever, and chest pain.
• Risk factors include immunosuppression, chronic lung disease, and prolonged antibiotic use.
• Diagnosis often involves imaging studies and microbiological cultures.
• Epidemiologically, it is more prevalent in individuals with weakened immune systems.

ICD-10 Code B44.9 for Aspergillosis, unspecified – SOAP Notes & Clinical Use

ICD-10 Code B44.9 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans for aspergillosis. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management.

What Does ICD-10 Code B44.9 for Aspergillosis, unspecified Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B44.9 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of aspergillosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B44.9 – Aspergillosis, unspecified

Aspergillosis, unspecified may require hospitalization, especially in severe cases. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• First-line: Voriconazole or Amphotericin B, typically for 6-12 weeks.
• Alternative: Posaconazole or Isavuconazole, depending on patient tolerance.
• Duration may vary based on clinical response and severity.

Supportive Care:

• Oxygen therapy for hypoxemia.
• Bronchodilators for wheezing and respiratory distress.
• Fluid management and nutritional support as needed.

Infection Control:

• Implement precautions to prevent airborne transmission.
• Educate patients on avoiding exposure to mold and dust.
• Monitor for outbreaks in healthcare settings.

How to Document Symptoms of Aspergillosis, unspecified (ICD-10 B44.9) in SOAP Notes

Subjective:

• Patient reports persistent cough and shortness of breath.
• History of recent exposure to moldy environments.
• Complaints of fever and fatigue over the past week.
• Known history of asthma and recent antibiotic use.

Objective:

• Wheezing noted on auscultation.
• Respiratory rate: 22 breaths per minute.
• Oxygen saturation: 92% on room air.
• Chest X-ray shows infiltrates consistent with fungal infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Aspergillosis, unspecified (ICD-10 Code B44.9)

Assessment:

• Diagnosis: Aspergillosis, unspecified, moderate severity.
• ICD-10 Code: B44.9.
• Triggers: Recent exposure to mold and history of asthma.
• Consideration of immunocompromised status.

Plan:

• Initiate antifungal therapy with Voriconazole.
• Educate patient on avoiding mold exposure.
• Monitor respiratory status and oxygen saturation.
• Schedule follow-up in one week to assess treatment response.

Treatment & Plan Section for ICD-10 Code B44.9 – Aspergillosis, unspecified

• First-line pharmacologic treatment includes Voriconazole or Amphotericin B.
• Non-pharmacologic strategies involve environmental control and patient education.
• Monitoring includes regular assessment of respiratory function and symptom tracking.
• Follow-up visits should be scheduled to evaluate treatment efficacy and adjust therapy as needed.

Using ICD-10 Code B44.9 for Aspergillosis, unspecified in Billing & SOAP Note Compliance

• Select appropriate documentation that clearly outlines symptoms and clinical findings.
• Ensure the use of B44.9 aligns with the patient's clinical presentation and treatment plan.
• Maintain compliance with coding guidelines to support justified billing.
• Document any relevant comorbidities that may affect treatment and billing.

Related ICD-10 Codes Often Used with Aspergillosis, unspecified

• B44.0 – Allergic Aspergillosis
• B44.1 – Aspergilloma

ICD-10 Code B44.9 in Medical Billing and Insurance for Aspergillosis, unspecified

ICD-10 Code B44.9 is critical in hospital, ER, or infectious disease care settings for accurate billing and documentation.

Billing Notes:

• Document all relevant clinical findings and patient history to support the use of B44.9.
• Ensure that the code is used in conjunction with appropriate CPT codes for services rendered.
• Maintain clear and concise notes to facilitate the billing process and reduce claim denials.

Common CPT Pairings: